carnitine has been researched along with Scleroderma, Systemic in 9 studies
Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.
Excerpt | Relevance | Reference |
---|---|---|
"L-propionylcarnitine (L-PC) is a metabolic substance that is associated with a beneficial effect on both microcirculation and myocyte function." | 2.73 | Effect of a single IV administration of L-propionylcarnitine on myocardial microcirculation assessed by coronary flow velocity reserve measurement in patients with systemic sclerosis: a pilot study. ( Cauli, A; Iliceto, S; Lai, S; Mathieu, A; Meloni, L; Montisci, M; Montisci, R; Passiu, G; Ruscazio, M; Vacca, A, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (55.56) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Ottria, A | 1 |
Hoekstra, AT | 1 |
Zimmermann, M | 1 |
van der Kroef, M | 1 |
Vazirpanah, N | 1 |
Cossu, M | 1 |
Chouri, E | 1 |
Rossato, M | 1 |
Beretta, L | 2 |
Tieland, RG | 1 |
Wichers, CGK | 1 |
Stigter, E | 1 |
Gulersonmez, C | 1 |
Bonte-Mineur, F | 1 |
Berkers, CR | 1 |
Radstake, TRDJ | 1 |
Marut, W | 1 |
Fernández-Ochoa, Á | 1 |
Quirantes-Piné, R | 1 |
Borrás-Linares, I | 1 |
Gemperline, D | 1 |
Alarcón Riquelme, ME | 1 |
Segura-Carretero, A | 1 |
Montisci, R | 1 |
Ruscazio, M | 1 |
Lai, S | 1 |
Vacca, A | 1 |
Cauli, A | 1 |
Passiu, G | 1 |
Montisci, M | 1 |
Meloni, L | 1 |
Mathieu, A | 1 |
Iliceto, S | 1 |
Famularo, G | 1 |
De Simone, C | 1 |
Danese, C | 1 |
Nitzschner, H | 3 |
Schneider, D | 1 |
Liebsch, F | 2 |
Strack, E | 1 |
Nitschner, H | 1 |
1 review available for carnitine and Scleroderma, Systemic
Article | Year |
---|---|
Carnitine deficiency in scleroderma.
Topics: Antioxidants; Carnitine; Humans; Scleroderma, Systemic | 1999 |
1 trial available for carnitine and Scleroderma, Systemic
Article | Year |
---|---|
Effect of a single IV administration of L-propionylcarnitine on myocardial microcirculation assessed by coronary flow velocity reserve measurement in patients with systemic sclerosis: a pilot study.
Topics: Adenosine; Adult; Aged; Blood Flow Velocity; Cardiotonic Agents; Cardiovascular Diseases; Carnitine; | 2007 |
7 other studies available for carnitine and Scleroderma, Systemic
Article | Year |
---|---|
Fatty Acid and Carnitine Metabolism Are Dysregulated in Systemic Sclerosis Patients.
Topics: Adult; Aged; Carnitine; Cohort Studies; Cytokines; Dendritic Cells; Etoposide; Fatty Acids; Female; | 2020 |
Urinary and plasma metabolite differences detected by HPLC-ESI-QTOF-MS in systemic sclerosis patients.
Topics: Acylation; Adult; Aged; Arachidonic Acids; Biomarkers; Carnitine; Case-Control Studies; Chromatograp | 2019 |
[Observations of the course of scleroderma after combined Hylase-carnitine therapy].
Topics: Carnitine; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Humans; Hyaluronoglucosaminid | 1975 |
[Treatment of progressive scleroderma using carnitine].
Topics: Adult; Blood Circulation; Carnitine; Dextrans; Drug Eruptions; Drug Evaluation; Drug Tolerance; Elas | 1974 |
[The course of scleroderma following treatment with carnitin].
Topics: Adult; Carnitine; Child; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Middle Aged | 1974 |
[Use of carnitine in connective tissue diseases].
Topics: Adult; Carnitine; Collagen Diseases; Female; Humans; Hyperthyroidism; Male; Middle Aged; Scleroderma | 1971 |
[Carnitine and diseases of the connective tissue].
Topics: Adult; Aged; Carnitine; Child; Collagen Diseases; Dermatomyositis; Dupuytren Contracture; Female; Hu | 1970 |